Kevin Joseph Fitzgerald - CSO & EVP, Head of Research at ALNYLAM PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
CSO & EVP, Head of Research
Issuer Symbol
ALNY on Nasdaq
All Insider Reports
All Insider Reports

Kevin Joseph Fitzgerald - trading volume in the past year for ALNYLAM PHARMACEUTICALS, INC.

Holdings reported by Kevin Joseph Fitzgerald for ALNYLAM PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 20,569 $6,710,430 $326.24 05 Mar 2026 Direct
Common Stock 537 $173,064 $322.28 04 Mar 2026 by Managed Account
Stock Option (right to buy) 8,105 02 Mar 2026 Direct Common Stock

Transactions reported by Kevin Joseph Fitzgerald for ALNYLAM PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.